Meyka Pro banner
VSee Health, Inc.

VSee Health, Inc. Fundamental Analysis (NASDAQ: VSEE)

VSEENASDAQ
HealthcareMedical - Healthcare Information Services
$0.03
$0.001(1.85%)
U.S. Market is Open · 15:44

VSee Health, Inc. Fundamental Analysis (NASDAQ: VSEE)

VSee Health, Inc. (NASDAQ: VSEE) shows weak financial fundamentals with a PE ratio of -0.06, profit margin of -1.10%, and ROE of -4.02%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position65.74%
PEG Ratio-0.00

Areas of Concern

ROE-4.02%
Operating Margin-82.36%
Current Ratio0.40
We analyze VSEE's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -581.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-581.2/100

We analyze VSEE's fundamental strength across five key dimensions:

Efficiency Score

Weak

VSEE struggles to generate sufficient returns from assets.

ROA > 10%
-82.80%

Valuation Score

Excellent

VSEE trades at attractive valuation levels.

PE < 25
-0.06
PEG Ratio < 2
-0.00

Growth Score

Weak

VSEE faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

VSEE shows balanced financial health with some risks.

Debt/Equity < 1
0.25
Current Ratio > 1
0.40

Profitability Score

Weak

VSEE struggles to sustain strong margins.

ROE > 15%
-401.91%
Net Margin ≥ 15%
-1.10%
Positive Free Cash Flow
No

Key Financial Metrics

Is VSEE Expensive or Cheap?

P/E Ratio

VSEE trades at -0.06 times earnings. This suggests potential undervaluation.

-0.06

PEG Ratio

When adjusting for growth, VSEE's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values VSee Health, Inc. at 0.09 times its book value. This may indicate undervaluation.

0.09

EV/EBITDA

Enterprise value stands at 0.10 times EBITDA. This is generally considered low.

0.10

How Well Does VSEE Make Money?

Net Profit Margin

For every $100 in sales, VSee Health, Inc. keeps $-1.10 as profit after all expenses.

-1.10%

Operating Margin

Core operations generate -82.36 in profit for every $100 in revenue, before interest and taxes.

-82.36%

ROE

Management delivers $-4.02 in profit for every $100 of shareholder equity.

-4.02%

ROA

VSee Health, Inc. generates $-82.80 in profit for every $100 in assets, demonstrating efficient asset deployment.

-82.80%

Following the Money - Real Cash Generation

Operating Cash Flow

VSee Health, Inc. generates limited operating cash flow of $-2.99M, signaling weaker underlying cash strength.

$-2.99M

Free Cash Flow

VSee Health, Inc. generates weak or negative free cash flow of $-3.00M, restricting financial flexibility.

$-3.00M

FCF Per Share

Each share generates $-0.18 in free cash annually.

$-0.18

FCF Yield

VSEE converts -13.05% of its market value into free cash.

-13.05%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.06

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.09

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.03

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.25

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.40

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-4.02

vs 25 benchmark

ROA

Return on assets percentage

-0.83

vs 25 benchmark

ROCE

Return on capital employed

-1.20

vs 25 benchmark

How VSEE Stacks Against Its Sector Peers

MetricVSEE ValueSector AveragePerformance
P/E Ratio-0.0631.19 Better (Cheaper)
ROE-401.91%447.00% Weak
Net Margin-109.72%21592.00% Weak
Debt/Equity0.250.54 Strong (Low Leverage)
Current Ratio0.405.66 Weak Liquidity
ROA-82.80%-52.00% (disorted) Weak

VSEE outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews VSee Health, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ